Advertisement
Canada markets close in 5 hours 50 minutes

  • S&P/TSX

    21,677.47
    -196.25 (-0.90%)
     

  • S&P 500

    4,998.56
    -73.07 (-1.44%)
     

  • DOW

    37,789.92
    -671.00 (-1.74%)
     

  • CAD/USD

    0.7287
    -0.0011 (-0.15%)
     

  • CRUDE OIL

    82.51
    -0.30 (-0.36%)
     

  • Bitcoin CAD

    87,175.19
    -3,618.18 (-3.99%)
     

  • CMC Crypto 200

    1,370.95
    -11.62 (-0.84%)
     

  • GOLD FUTURES

    2,330.50
    -7.90 (-0.34%)
     

  • RUSSELL 2000

    1,960.18
    -35.25 (-1.77%)
     

  • 10-Yr Bond

    4.7250
    +0.0730 (+1.57%)
     

  • NASDAQ

    15,430.94
    -281.81 (-1.79%)
     

  • VOLATILITY

    17.33
    +1.36 (+8.51%)
     

  • FTSE

    8,041.35
    +0.97 (+0.01%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6810
    -0.0009 (-0.13%)
     
MARKETS LIVE BLOG:

STOCKS SLIDE AFTER META'S REALITY CHECK, WITH GDP ON DECK

Owner of Facebook and Instagram plans to spend up to US$10B on AI infrastructure investments

Five Star Equities Issues New Research Reports on ATRM, BIOS, BYD and ELTK

ACCESSWIRE

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.

Aetrium, Inc. (NASDAQ:ATRM - News) shares soared 156.20 percent to close at $12.40 a share Wednesday. The stock traded between $5.70 and $12.40 on 2.43 million shares traded. The company last week announced that it had received orders for multiple units of its VMAX IC test handlers.

Get more information on Aetrium free access to the in-depth equity report at:
www.FiveStarEquities.com/ATRM

BioScrip Inc. (NASDAQ:BIOS - News) shares gained 17.29 percent to close at $6.92 a share Wednesday. The stock traded between $6.15 and $7.42 on volume 7.33 million shares traded. Shares spiked as CVS Caremark announced it had acquired Bioscip’s peer Coram LLC from Apria Healthcare Group Inc. for approximately $2.1 billion. Shares of BioScrip have fallen approximately 35.0 percent year-to-date.

ADVERTISEMENT

Get more information on BioScrip and free access to the in-depth equity report at:
www.FiveStarEquities.com/BIOS

Boyd Gaming Corporation (NYSE:BYD - News) shares jumped 9.94 percent to close at $11.50 a share Wednesday. The stock traded between $10.44 and $11.50 on volume 5.51 million shares traded. The company on Tuesday announced that it had launched online gaming operations in New Jersey. Shares of Boyd Gaming have gained approximately 70.0 percent year-to-date.

Get more information on Boyd Gaming and free access to the in-depth equity report at:
www.FiveStarEquities.com/BYD

Eltek Ltd. (NASDAQ:ELTK - News) shares soared 49.77 percent to close at $3.19 a share Wednesday. The stock traded between $3.07 and $3.95 on volume of 11.35 million shares traded. The company reported a net profit of $585,000 for the third quarter of 2013, compared to a net profit of $135,000 a year ago. Shares of Eltek have gained approximately 190.0 percent year-to-date.

Get more information on Eltek and free access to the in-depth equity report at:
www.FiveStarEquities.com/ELTK

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com